Search

Your search keyword '"Weder W"' showing total 29 results
Start Over Author "Weder W" Journal annals of oncology
29 results on '"Weder W"'

2. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

Author

Kerr, K.M., Dafni, U., Schulze, K., Thunnissen, E., Bubendorf, L., Hager, H., Finn, S., Biernat, W., Vliegen, L., Losa, J.H., Marchetti, A., Cheney, R., Warth, A., Speel, E.-J., Blackhall, F., Monkhorst, K., Jantus Lewintre, E., Tischler, V., Clark, C., Bertran-Alamillo, J., Meldgaard, P., Gately, K., Wrona, A., Vandenberghe, P., Felip, E., De Luca, G., Savic, S., Muley, T., Smit, E.F., Dingemans, A.-M.C., Priest, L., Baas, P., Camps, C., Weder, W., Polydoropoulou, V., Geiger, T.R., Kammler, R., Sumiyoshi, T., Molina, M.A., Shames, D.S., Stahel, R.A., and Peters, S.

Published
2018
Full Text
View/download PDF

3. 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

Author

Eberhardt, W.E.E., De Ruysscher, D., Weder, W., Le Péchoux, C., De Leyn, P., Hoffmann, H., Westeel, V., Stahel, R., Felip, E., Peters, S., Stahel, Rolf, Felip, Enriqueta, Peters, Solange, Kerr, Keith, Besse, Benjamin, Vansteenkiste, Johan, Eberhardt, Wilfried, Edelman, Martin, Mok, Tony, O'Byrne, Ken, Novello, Silvia, Bubendorf, Lukas, Marchetti, Antonio, Baas, Paul, Reck, Martin, Syrigos, Konstantinos, Paz-Ares, Luis, Smit, Egbert F., Meldgaard, Peter, Adjei, Alex, Nicolson, Marianne, Crinó, Lucio, Van Schil, Paul, Senan, Suresh, Faivre-Finn, Corinne, Rocco, Gaetano, Veronesi, Giulia, Douillard, Jean-Yves, Lim, Eric, Dooms, Christophe, Weder, Walter, De Ruysscher, Dirk, Le Pechoux, Cecile, De Leyn, Paul, and Westeel, Virginie

Published
2015
Full Text
View/download PDF

5. 929MO Platform study of neoadjuvant durvalumab (D) alone or combined with novel agents in patients (pts) with resectable, early-stage non-small cell lung cancer (NSCLC): Pharmacodynamic correlates and circulating tumor DNA (ctDNA) dynamics in the NeoCOAST study

Author

Spicer, J., primary, Cascone, T., additional, Kar, G., additional, Zheng, Y., additional, Blando, J., additional, Tan, T.H., additional, Cheng, M., additional, Mager, R., additional, Hamid, O., additional, Soo-Hoo, Y., additional, Forde, P.M., additional, Weder, W., additional, Garcia Campelo, M.R., additional, Grenga, I., additional, Kumar, R., additional, and McGrath, L., additional

Published
2022
Full Text
View/download PDF

12. Local delivery of CAR T cells targeting fibroblast activation protein is safe in patients with pleural mesothelioma: first report of FAPME, a phase I clinical trial

Author

Hiltbrunner, S., primary, Britschgi, C., additional, Schuberth, P., additional, Bankel, L., additional, Nguyen-Kim, T.D.L., additional, Gulati, P., additional, Weder, W., additional, Opitz, I., additional, Lauk, O., additional, Caviezel, C., additional, Bachmann, H., additional, Tabor, A., additional, Schröder, P., additional, Knuth, A., additional, Münz, C., additional, Stahel, R., additional, Boyman, O., additional, Renner, C., additional, Petrausch, U., additional, and Curioni-Fontecedro, A., additional

Published
2021
Full Text
View/download PDF

15. A phase I clinical trial of malignant pleural mesothelioma treated with locally delivered autologous anti-FAP-targeted CAR T-cells

Author

Curioni, A., primary, Britschgi, C., additional, Hiltbrunner, S., additional, Bankel, L., additional, Gulati, P., additional, Weder, W., additional, Opitz, I., additional, Lauk, O., additional, Caviezel, C., additional, Knuth, A., additional, Münz, C., additional, Renner, C., additional, Stahel, R.A., additional, and Petrausch, U., additional

Published
2019
Full Text
View/download PDF

16. Survival outcome of non-small cell lung cancer (NSCLC) patients: Comparing results between the database of the Comprehensive Cancer Center Zürich (CCCZ) and the Epidemiological Cancer Registry Zurich and Zug (KKR)

Author

Stahel, R.A., primary, Curioni, A., additional, Rohrmann, S., additional, Dafni, U., additional, Sandner, U., additional, Andratschke, N., additional, Dimopoulou, G., additional, Guckenberger, M., additional, Kohler, M., additional, Matthes, K., additional, Opitz, I., additional, and Weder, W., additional

Published
2019
Full Text
View/download PDF

22. Final Results of the Sakk 16/00 Trial: a Randomized Phase III Trial Comparing Neoadjuvant Chemoradiation to Chemotherapy Alone in Stage Iiia/N2 Non-Small Cell Lung Cancer (Nsclc)

Author

Pless, M., primary, Stupp, R., additional, Ris, H., additional, Stahel, R.A., additional, Weder, W., additional, Thierstein, S., additional, Xyrafas, A., additional, Früh, M., additional, Cathomas, R., additional, Zippelius, A., additional, Roth, A.D., additional, Ochsenbein, A., additional, Meier, U.R., additional, Mamot, C., additional, Rauch, D., additional, Gautschi, O., additional, Gerard, M., additional, Betticher, D.C., additional, Mirimanoff, R.O., additional, and Peters, S., additional

Published
2014
Full Text
View/download PDF

23. Neoadjuvant Chemotherapy and Extrapleural Pneumonectomy (Epp) of Malignant Pleural Mesothelioma (Mpm) with or Without Hemithoracic Radiotherapy: Final Results of the Randomized Multicenter Phase Ii Trial Sakk17/04

Author

Stahel, R.A., primary, Riesterer, O., additional, Alexandros, X., additional, Opitz, I., additional, Beyeler, M., additional, Ochsenbein, A., additional, Früh, M., additional, Cathomas, R., additional, Nackaerts, K., additional, Peters, S., additional, Mamot, C., additional, Zippelius, A., additional, Mordasini, C., additional, Clemens, K., additional, Eckhardt, K., additional, Schmid, R., additional, Nagel, W., additional, Aebersold, D., additional, Gautschi, O., additional, and Weder, W., additional

Published
2014
Full Text
View/download PDF

24. The European Thoracic Oncology Platform Lungscape Project: A Way to Bridge Non-Small Cell Lung Cancer Molecular Characteristics and Clinical Data

Author

Peters, S., primary, Dafni, O., additional, Bubendorf, L., additional, Meldgaard, P., additional, O'Byrne, K., additional, Wrona, A., additional, Weder, W., additional, Canela, M., additional, Malatesta, S., additional, Vansteenkiste, J., additional, Dingemans, A.-M., additional, Nicolson, M., additional, Savic, S., additional, Baas, P., additional, Peck, R., additional, Lu, S., additional, Smit, E., additional, Jantus-Lewintre, E., additional, Rosell, R., additional, and Stahel, R.A., additional

Published
2012
Full Text
View/download PDF

26. LBA37_PR - Neoadjuvant Chemotherapy and Extrapleural Pneumonectomy (Epp) of Malignant Pleural Mesothelioma (Mpm) with or Without Hemithoracic Radiotherapy: Final Results of the Randomized Multicenter Phase Ii Trial Sakk17/04

Author

Stahel, R.A., Riesterer, O., Alexandros, X., Opitz, I., Beyeler, M., Ochsenbein, A., Früh, M., Cathomas, R., Nackaerts, K., Peters, S., Mamot, C., Zippelius, A., Mordasini, C., Clemens, K., Eckhardt, K., Schmid, R., Nagel, W., Aebersold, D., Gautschi, O., and Weder, W.

Published
2014
Full Text
View/download PDF

27. 1195O - Final Results of the Sakk 16/00 Trial: a Randomized Phase III Trial Comparing Neoadjuvant Chemoradiation to Chemotherapy Alone in Stage Iiia/N2 Non-Small Cell Lung Cancer (Nsclc)

Author

Pless, M., Stupp, R., Ris, H., Stahel, R.A., Weder, W., Thierstein, S., Xyrafas, A., Früh, M., Cathomas, R., Zippelius, A., Roth, A.D., Ochsenbein, A., Meier, U.R., Mamot, C., Rauch, D., Gautschi, O., Gerard, M., Betticher, D.C., Mirimanoff, R.O., and Peters, S.

Published
2014
Full Text
View/download PDF

29. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease

Author

Benjamin Besse, Cécile Le Péchoux, Gaetano Rocco, Wilfried Eberhardt, Walter Weder, Solange Peters, Antonio Marchetti, Peter Meldgaard, Dirk De Ruysscher, S. Peters, Rolf A. Stahel, E. Felip, Giulia Veronesi, Alex A. Adjei, Suresh Senan, Egbert F. Smit, Christophe Dooms, M. Nicolson, Keith M. Kerr, Jean-Yves Douillard, Lucio Crinò, Kenneth J. O'Byrne, Lukas Bubendorf, Paul Baas, P. Meldgaard, E. F. Smit, Corinne Faivre-Finn, Marianne Nicolson, P. Baas, A. A. Adjei, Silvia Novello, Paul De Leyn, Luis Paz-Ares, Tony Mok, Enriqueta Felip, Martin Reck, Martin J. Edelman, Paul Van Schil, Virginie Westeel, Konstantinos N. Syrigos, Eric Lim, Johan Vansteenkiste, Kostas N. Syrigos, University of Zurich, Besse, B, Eberhardt, Wilfried (Beitragende*r), Pulmonary medicine, CCA - Innovative therapy, Panel Members, Stahel, R., Felip, E., Peters, S., Kerr, K., Besse, B., Vansteenkiste, J., Eberhardt, W., Edelman, M., Mok, T., O'Byrne, K., Novello, S., Bubendorf, L., Marchetti, A., Baas, P., Reck, M., Syrigos, K., Paz-Ares, L., Smit, EF., Meldgaard, P., Adjei, A., Nicolson, M., Crinò, L., Van Schil, P., Senan, S., Faivre-Finn, C., Rocco, G., Veronesi, G., Douillard, JY., Lim, E., Dooms, C., Weder, W., De Ruysscher, D., Le Pechoux, C., De Leyn, P., and Westeel, V.

Subjects
Oncology, Lung Neoplasms, 10255 Clinic for Thoracic Surgery, 2720 Hematology, Medizin, Angiogenesis Inhibitors, Disease, Carboplatin, DOUBLE-BLIND, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Advanced disease, ELDERLY-PATIENTS, Drug Substitution, Age Factors, Consensus conference, PHASE-III TRIAL, Hematology, RANDOMIZED CONTROLLED-TRIAL, respiratory system, OPEN-LABEL, Combined Modality Therapy, Neoadjuvant Therapy, Chemotherapy, Adjuvant, Existing Treatment, 2730 Oncology, Non small cell, medicine.medical_specialty, Consensus, First line, 610 Medicine & health, PLATINUM-BASED CHEMOTHERAPY, CISPLATIN PLUS GEMCITABINE, TYROSINE KINASE INHIBITORS, INDIVIDUAL PATIENT DATA, SUPPORTIVE CARE, Maintenance Chemotherapy, Internal medicine, medicine, Humans, Lung cancer, Aged, business.industry, Evidence-based medicine, medicine.disease, respiratory tract diseases, 10032 Clinic for Oncology and Hematology, Cisplatin, business
Abstract

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines of treatment in advanced disease, early-stage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on first line/second and further lines of treatment in advanced disease.

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results